Zydus Lifesciences Limited (ZYDUSLIFE)

Current Price: ₹0.00

Back to Home
Stock Performance

Quarterly Financials

Consolidated Standalone
Particulars Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Revenue from Operations 2,579.30 2,955.70 2,159.30 2,371.30 3,332.40 4,160.20 2,620.60 2,515.90 5,819.60 2,588.30 2,871.20 2,283.60
YOY Revenue Growth % 27.73% 49.21% -9.98% 13.63% 29.2% 40.75% 21.36% 6.1% 74.64% -37.78% 9.56% -9.23%
Other Income 251.20 82.40 534.50 106.80 361.10 106.60 326.70 77.50 185.40 157.10 541.50 473.80
Total Income 2,830.50 3,038.10 2,693.80 2,478.10 3,693.50 4,266.80 2,947.30 2,593.40 6,005.00 2,745.40 3,412.70 2,757.40
Total Expenses + 1,744.00 1,742.70 1,508.50 1,579.00 1,778.30 1,775.00 1,730.20 1,567.50 2,330.30 2,270.50 1,969.10 2,344.90
Cost of Materials Consumed 806.70 876.70 705.90 681.60 737.20 725.70 704.80 635.80 720.80 853.70 890.80 849.50
Employee Benefit Expense 353.10 351.70 377.70 373.00 405.10 424.40 436.50 425.00 476.30 487.20 468.70 496.40
Other Expenses 584.20 514.30 424.90 524.40 636.00 624.90 588.90 506.70 880.40 611.90 407.60 707.60
Operating Profit 835.30 1,213.00 650.80 792.30 1,554.10 2,385.20 890.40 948.40 3,489.30 317.80 902.10 -61.30
OPM % 32.4% 41% 30.1% 33.4% 46.6% 57.3% 34% 37.7% 60% 12.3% 31.4% -2.7%
Profit Before Tax + 615.00 1,012.50 968.10 574.30 1,684.90 2,233.50 1,039.30 497.20 3,674.70 474.90 1,443.60 352.40
Tax Expense 124.30 231.60 163.10 123.90 279.70 532.70 249.50 26.60 861.00 90.20 287.00 55.90
Tax % 20.2% 22.9% 16.8% 21.6% 16.6% 23.9% 24% 5.3% 23.4% 19% 19.9% 15.9%
Profit After Tax 490.70 780.90 805.00 450.40 1,405.20 1,700.80 789.80 470.60 2,813.70 384.70 1,156.60 296.50
EPS (Basic) 4.85 7.71 7.96 4.45 13.89 16.90 7.85 4.68 27.96 3.82 11.49 2.95

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
Revenue from Operations 15,116.30 10,818.70 8,731.60 7,981.90
YOY Revenue Growth % 39.72% 23.9% 9.39% -
Other Income 696.20 1,084.80 548.40 178.70
Total Income 15,812.50 11,903.50 9,280.00 8,160.60
Total Expenses + 8,367.80 6,608.50 5,809.40 5,822.60
Cost of Materials Consumed 2,787.10 3,001.40 2,703.50 2,629.00
Employee Benefit Expense 1,762.20 1,507.50 1,321.90 1,204.90
Other Expenses 2,600.90 2,099.60 1,784.00 1,988.70
Operating Profit 6,748.50 4,210.20 2,922.20 2,159.30
OPM % 44.6% 38.9% 33.5% 27.1%
Profit Before Exceptional 7,444.70 4,248.40 2,236.00 1,483.20
Exceptional Items 0.00 -8.60 -203.80 -319.30
Profit Before Tax + 7,444.70 4,239.80 2,032.20 1,163.90
Tax Expense 1,669.80 798.30 503.00 306.00
Tax % 22.4% 18.8% 24.8% 26.3%
Profit After Tax 5,774.90 3,441.50 1,529.20 857.90
EPS (Basic) 57.39 34.01 15.06 8.38

Balance Sheet

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
ASSETS
Non-Current Assets + 17,002.20 16,149.00 13,405.40 0.00
Property, Plant & Equipment 4,135.80 4,325.70 4,141.80 0.00
Capital Work in Progress 1,188.50 626.70 739.30 0.00
Non-Current Investments 7,255.00 7,283.00 4,677.70 0.00
Goodwill 0.00 0.00 0.00 0.00
Other Intangible Assets 66.30 43.70 42.30 0.00
Current Assets + 15,314.70 7,911.30 7,158.20 0.00
Inventories 1,952.10 1,687.30 1,782.40 0.00
Trade Receivables 8,161.80 4,740.10 3,505.30 0.00
Cash and Cash Equivalents 103.00 108.10 240.40 0.00
Current Investments 1,000.00 0.00 201.60 0.00
LIABILITIES & EQUITY
Total Equity 0.00 0.00 0.00 0.00
Equity Share Capital 100.60 100.60 101.20 0.00
Other Equity 21,089.50 15,615.90 13,538.20 0.00
Non-Current Liabilities 3,275.40 5,826.90 4,134.10 0.00
Current Liabilities 7,851.40 2,541.40 2,790.10 0.00
Total Liabilities 11,126.80 8,368.30 6,924.20 0.00

Cash Flow Statement

Particulars Mar 2025 Mar 2024 Mar 2023 Mar 2022
Cash from Operating Activities 3,114.00 1,999.10 1,078.20 1,310.70
Cash from Investing Activities -4,503.60 -1,830.60 -1,959.70 768.20
Cash from Financing Activities 1,384.50 -300.80 827.00 -1,709.80
Net Increase/Decrease in Cash -5.10 -132.30 -54.50 369.10